How Diet and Exercise Change Your Hunger and Fullness Hormones When You're Obese

Researchers enrolled 62 obese individuals (BMI ≥30) and 48 healthy-weight controls. The obese group followed a 12-week program combining a calorie-restricted diet (1,000–1,500 kcal/day, tailored to age, gender, and BMI) with daily exercise (at least 5,000 steps/day). Blood samples were taken before and after the 12-week period, and ghrelin, GLP-1, and PYY levels were measured using ELISA assays.

Understanding how diet and exercise affect appetite peptides helps explain why these interventions work — and why they sometimes aren't enough. The finding that GLP-1 and PYY didn't normalize even after treatment provides biological context for why many people struggle to maintain weight loss, and why GLP-1 agonist drugs like semaglutide have become so popular: they may compensate for a deficit that lifestyle changes alone can't fully correct.

This study adds to growing evidence that obesity involves a fundamental disruption of appetite-regulating peptide signaling — not just a lack of willpower. The persistent gap between obese and healthy-weight hormone levels, even after successful intervention, helps explain the biological basis for weight regain and provides context for why pharmacological GLP-1 agonists have proven so effective: they may be correcting a peptide deficit that the body struggles to fix on its own.

The study used a relatively modest exercise target (5,000 steps/day, which is below most health recommendations). The abstract doesn't report the actual amount of weight lost, making it harder to connect the hormone changes to specific outcomes. There was no randomization or blinding described, and the control group didn't undergo the intervention, limiting causal conclusions. The ELISA methodology may also be less precise than newer assay techniques.